The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
signed contracts in the past week with the London Eye, a further four aquariums and with its first European zoo partner. Additionally, the Company has agreed terms, subject to contract, with a further nine aquariums and five entertainment sites. The aggregate total across the sites (contractually agreed and subject to contract) is 93 headsets, all of which are scheduled to be installed during Q1 2020.
"We are thrilled to be collaborating with eOne, a global entertainment brand, to create an exciting new BRICKLIVE tour of one of the world's most popular pre-school children's brands, Peppa Pig. eOne has become the Group's third international IP partner in less than 12 months which is a significant milestone for the Group and BRICKLIVE.
BRICKLIVE continues to create fresh, engaging and interactive tours that appeal to young children, demonstrating our strength and appeal to international children's brands. We look forward to working with the eOne team and launching the first tour in Q3 2020."
Two cannabis-based medicines, used to treat epilepsy and multiple sclerosis, have been approved for use by the NHS in England.
It follows new guidelines from the drugs advisory body NICE, which looked at products for several conditions.
Charities have welcomed the move, although some campaigners who have been fighting for access to the drugs have said it does not go far enough.
Both medicines were developed in the UK, where they are also grown.
Doctors will be able to prescribe Epidyolex, for children with two types of severe epilepsy - Lennox Gastaut syndrome and Dravet syndrome - which can cause multiple seizures a day.
Clinical trials have shown the oral solution, which contains cannabidiol (CBD), could reduce the number of seizures by up to 40% in some children.
The European Commission has approved under EU State aid rules the British Capacity Market scheme ("the Scheme") introduced in 2014 to safeguard security of electricity supply. Notably, the Commission did not find any evidence that the Scheme would put demand response operators or any other capacity providers at a disadvantage with respect to their participation in the Scheme.
This ruling overturns the previous capacity market suspension by the EU in November 2018, which was delaying a significant number of customer investment decisions particularly in relation to Dunamis's high voltage design and build business, which was reported in the Company trading statement 28 March 2019.
From a standing start, we have established a vertically integrated CBD business with sales on both sides of the Atlantic and growing relationships with significant distribution partners. Our focus in these past few months has been to establish these relationships. For the remainder of the year we can look forward to advancing sales with our partners.
Revenue up 20.4% to £48.9 million (2018 restated: £40.6 million)
· Adjusted EBITDA* up 16.8% to £10.0 million (2018 restated: £8.6 million)
· Profit before tax of £6.0 million (2018 restated: £6.9 million) and adjusted profit before tax* of £8.6 million (2018 restated: £7.9 million)
· Net cash inflows from operations of £3.5 million (2018: £3.1 million)
· Adjusted earnings per share of 3.5p (2018 restated: 4.3p) and basic earnings per share of 2.3p (2018 restated: 3.7p)
· Net cash of £3.8 million as at 31 March 2019 (2018: £9.4 million)
· Net assets per share up 17.8% to 20.5p
· The financial statements for FY2019 reflect the adoption of IFRS15 Revenue from Contracts with Customers and the results for FY2018 have been restated (see next page for impact statement)
Dividend
· The Board is recommending a final dividend of 1.5p per share (2018: 1.4p per share) resulting in a full-year dividend of 2.25p per share (2018: 2.1p), an increase of 7.1% against the prior year
· The dividend reflects the Board's ongoing confidence in the Group's ability to generate cash and its future prospects.
Although Coho-1 targeted the smallest prospect in our Ortoire exploration inventory, the initial drilling results represent significant potential growth for the Company. The presence of hydrocarbons in the turbidite sands of the Herrera confirms that our geological model is correct, and our drilling operations confirm that our team can drill future wells in a safe, timely and cost-efficient manner. This result gives the Board and Management a great deal of confidence to move directly to the Cascadura location which will test a separate structure targeting significant oil prospects in a similar geological setting."
Andrew Benitz, CEO of Jersey Oil & Gas, commented:
"We are delighted to announce this further licence award within the Greater Buchan Area. This additional acreage completes a 100 per cent. success rate of awards across all of the acreage we applied for in the 31st Supplementary Offshore Licensing Round. The Glenn oil discovery contained therein adds additional discovered resources net to JOG as well as operatorship of another discovered resource in the area of our Buchan-centred development hub plans for the GBA."
They have announced that the Group has entered into an agreement with HADRAN 2006 D.S Marketing and Tickets Distribution Ltd to supply brick-based content for an event to be held at the Holon Toto Arena, Holon, Israel from 25 July to 31 August 2019.
I reckon results out tomorrow